Publication | Closed Access

Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist

Apoptotic MarkersHormonal ReceptorGynecologyPathologyGonadotropin-releasing Hormone AgonistReproductive MedicinePublic HealthEndocrinologyMedicineOvarian HormoneEndocrine-related CancerOvarian Cancer